Last updated on March 2020

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Brief description of study

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.

Clinical Study Identifier: NCT03915964

Find a site near you

Start Over

NetCare Private Hosptial

Umhlanga, South Africa
  Connect »

Randles Road Medical Centre

Durban, South Africa
  Connect »